{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-009177","form_type":"8-K","ticker":"FEMY","cik":"0001339005","company_name":"FEMASYS INC","filed_at":"2025-03-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.386713+00:00","generated_at":"2026-05-24T13:22:49.666657+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Femasys secures first EU distribution partners in Spain for FemBloc birth control","bullets":["Partners are Comercial Medico Quirurigca (northern Spain) and Durgalab (southern Spain).","Both distributors previously commercialized Conceptus Essure, a non-surgical permanent birth control product.","This marks FemBloc's first entry into the European market via distribution partnerships.","CEO Kathy-Lee Sepsick called the milestone 'significant' in expanding innovative women's health technologies globally."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-009177","json":"https://secwatch.observer/filing/0001140361-25-009177.json","markdown":"https://secwatch.observer/filing/0001140361-25-009177.md","text":"https://secwatch.observer/filing/0001140361-25-009177.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1339005/000114036125009177/0001140361-25-009177-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1339005/000114036125009177/ef20045709_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T13:22:49.666657+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}